InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-26 | 2026-03-30 | Shannon James Samuel | Director | Purchase | 5,000 | $8.79 | $44K | 10.0K | View ↗ |
No annual data found.
Xilio Therapeutics reports Q1 results
Xilio Therapeutics, Inc. (XLO) Reports Q1 Loss, Beats Revenue Estimates
Opus Genetics, Inc. (IRD) Reports Q1 Loss, Misses Revenue Estimates
Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates